Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Predicted Market Size Of The Platelet Rich Plasma Industry By 2029?

In recent years, the market size for platelet rich plasma has experienced swift expansion. The projections indicate that it is set to rise from $0.71 billion in 2024 to $0.83 billion in 2025, registering a compound annual growth rate (CAGR) of 16.4%. This considerable growth during the historic term can be owed to the increasing demand for minimally invasive procedures, the escalating prevalence of chronic conditions like arthritis, the intensified emphasis on managing pain and recuperating from injuries, the expanded use of PRP within the field of veterinary medicine, and the rise in disposable income alongside healthcare spending.

The market size of platelet rich plasma is anticipated to expand significantly in the coming years, reaching an estimated $1.49 billion by 2029, representing a compound annual growth rate (CAGR) of 16.0%. This predicted expansion within the forecast period is largely due to an increased occurrence of sports-related injuries, a rise in orthopedic disorders, a growing demand for cosmetic and aesthetic procedures, an ageing population suffering from age-associated ailments, and an increasing number of clinical trials affirming the effectiveness of PRP. Key trends identified within the forecast period incorporate advancements in technology specific to platelet-rich plasma processing systems, new recent developments, the discovery of novel applications for platelet-rich plasma therapy, continual research and innovation, along with growing investments.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16150&type=smp

Which Growth Drivers Are Shaping The Platelet Rich Plasma Market Outlook?

The escalation in sports injuries occurrences is predicted to stimulate the expansion of the platelet-rich plasma market in the future. This increase can be attributed to a rise in sports participation, more youths enrolling in sports programs, factors related to aging, and lack of proper coaching and supervision. The application of Platelet-rich plasma (PRP) therapy in treatment enhances the healing process for sports injuries by facilitating tissue repair and regeneration, decreasing inflammation, and expediting the healing of tendons and ligaments. This therapy offers athletes a less intrusive treatment alternative that could potentially lead to quicker recovery times. As an example, in November 2023, Howden Group Holdings Ltd, a UK-originated insurance brokerage firm, reported that in October 2022, there were 88 documented injuries that caused players to be out for an average of 11.35 days pre-tournament, while in January 2023, the post-tournament figure escalated to 19.41 days. The report suggests that within this period, the severity of ankle, calf/shin, and hamstring injuries surged notably, with increments of 170%, 200%, and 130% respectively. Resultantly, this surge in the occurrence of sports injuries is prompting the growth of the platelet-rich plasma market.

How Is The Global Platelet Rich Plasma Market Broken Down By Segment?

The platelet rich plasmamarket covered in this report is segmented –

1) By Type: Pure Platelet Rich Plasma; Leukocyte-Rich Platelet Rich Plasma; Leukocyte-Rich Fibrin; Other Types

2) By Origin: Allogeneic Platelet Rich Plasma; Autologous Platelet Rich Plasma; Homologous Platelet Rich Plasma

3) By Application: Cosmetic Surgery And Aesthetics; General Surgery; Neurosurgery; Orthopedic And Spinal Surgery; Other Applications

4) By End User: Hospitals And Clinics; Research Institutes; Other End-Users

Subsegments:

1) By Pure Platelet Rich Plasma: Low Concentration PRP; High Concentration PRP

2) By Leukocyte-Rich Platelet Rich Plasma: Autologous LR-PRP; Allogeneic LR-PRP

3) By Leukocyte-Rich Fibrin: Injectable Leukocyte-Rich Fibrin; Membrane Leukocyte-Rich Fibrin

4) By Other Types: Platelet Rich Fibrin (PRF); Concentrated Platelet-Rich Plasma (cPRP); Platelet-Poor Plasma (PPP)

Which Trends Are Likely To Redefine Growth Paths In The Platelet Rich Plasma Market?

Leading corporations in the platelet-rich plasma market are innovating and creating ready-to-use plasma products. These shifts aim to cater to the increasing demand for top-notch PRP procedures in the aesthetics industry. The availability of a ready-to-use platelet-rich plasma (PRP) product implies a ready-to-administer solution for therapy, ensuring a uniform platelet dosage and effectiveness without the need for individual preparation. In July 2023, 4T Medical, a UK-based firm specializing in cosmeceuticals and medical aesthetic products, introduced a labelled PRP kit to the public. This medical device, registered under CE 2195, is specially designed to prepare autologous PRP, effectively enhancing skin rejuvenation and healing. The product offering includes two 10-ml test tubes equipped with a sodium citrate anticoagulant and all necessary items for blood collection. Upon centrifugation, the identification and injection of PRP becomes an easy process, enhancing healing, stimulating collagen production, tightening the skin, and promoting hair growth.

Who Are The Primary Market Leaders In The Platelet Rich Plasma Market?

Major companies operating in the platelet rich plasma market are Johnson & Johnson Services Inc., Stryker, Zimmer Biomet, Terumo Corporation, Arthrex Inc., Pall Corporation, Globus Medical, LifeNet Health, Exactech Inc., BioBridge Global, Regen Lab SA, Celling Biosciences Inc., Eclipse Aesthetics LLC, Regenexx, Isto Biologics, Royal Biologics, Apex Biologix, EmCyte Corporation, Medira Ltd., Nuo Therapeutics Inc., Juventix Regenerative Medical LLC., Estar Medical, Dr PRP USA LLC, MDBiologix, Vivostat A/S

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/platelet-rich-plasma-global-market-report

Which Regional Markets Are Emerging As Key Hubs For The Platelet Rich Plasma Market?

North America was the largest region in the platelet-rich plasma market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the platelet rich plasma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=16150&type=smp

Browse Through More Reports Similar to the Global Platelet Rich Plasma Market 2025, By The Business Research Company

Convalescent Plasma Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-global-market-report

Plasmas Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/plasmas-therapy-global-market-report

Mycoplasma Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/mycoplasma-testing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model